The EVP & CFO of Healthsouth Corp. (NYSE: HLS) is Buying SharesBy Carrie Williams
This recent transaction increases Douglas Coltharp’s holding in the company by 6.57% to a total of $2.92 million. In addition to Douglas Coltharp, 7 other HLS executives reported Buy trades in the last month.
Based on Healthsouth Corp.’s latest earnings report for the quarter ending September 30, the company posted quarterly revenue of $912 million and quarterly net profit of $61.5 million. In comparison, last year the company earned revenue of $768 million and had a net profit of $50.4 million. The company has a one year high of $43.38 and a one year low of $30.26. HLS’s market cap is $3.55B and the company has a P/E ratio of 16.56.
Six different firms, including JMP Securities and Raymond James, currently also have a Buy rating on the stock. Based on 3 analyst ratings, the analyst consensus is Moderate Buy with an average price target of $38.00, reflecting a 6.1% upside.
The insider sentiment on Healthsouth Corp. has been negative according to 93 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
HealthSouth Corp. engages in the provision of post-acute healthcare services. It operates through the Impatient Rehabilitation and Home Health and Hospice segments. The Impatient Rehabilitation segment operates inpatient rehabilitation hospitals that provide specialized rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders; cardiac and pulmonary conditions; brain and spinal cord injuries; complex orthopedic conditions; and amputations. The Home Health and Hospice segment provides Medicare-certified home nursing, specialized home care, and in-home services. The company was founded by Richard M. Scrushy on February 22, 1984 and is headquartered in Birmingham, AL.